Microbiome of HIV-infected people

Microbial Pathogenesis

Volumn 106, Issue , 2017, Pages 85-93

  Dubourg, Grégory ^a,b   Surenaud, Mathieu ^c,d,e   Lévy, Yves ^c,d,e,f   Hüe, Sophie ^c,d,e,f   Raoult, Didier ^a,b  

^a TIMONE HOSPITAL   (France)

^b INSERM   (France)

^c INSERM U955   (France)

^d FACULTÉ DE MÉDECINE   (France)

^e Vaccine Research Institute   (France)

^f HENRI MONDOR HOSPITAL   (France)

Author keywords

Diversity; Gut; HIV AIDS; Immunity; Microbiota; Translocation

Indexed keywords

ANTIRETROVIRUS AGENT; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 22; TRANSCRIPTION FACTOR FOXP3;

BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTEROIDES; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CLOSTRIDIA; DISEASE COURSE; ENTEROBACTERIACEAE; ENZYME ACTIVITY; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNITY; INFECTION SENSITIVITY; INTESTINE FLORA; LYMPHOCYTE SUBPOPULATION; MICROBIAL COLONIZATION; MICROBIAL DIVERSITY; NONHUMAN; PREVOTELLA; REVIEW; ADAPTIVE IMMUNITY; BACTERIUM; BIODIVERSITY; CLASSIFICATION; COMPLICATION; GASTROINTESTINAL TRACT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MICROBIOLOGY; VIRUS REPLICATION;

ADAPTIVE IMMUNITY; BACTERIA; BIODIVERSITY; DISEASE PROGRESSION; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HIV INFECTIONS; HIV-1; HOMEOSTASIS; HUMANS; VIRUS REPLICATION;

EID: 84969812939     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2016.05.015     Document Type: Review

References (92)

1. [1] Rodriguez, C., Taminiau, B., Van, B.J., Delmee, M., Daube, G., Clostridium difficile infection and intestinal microbiota interactions. Microb. Pathog. 89 (2015 Nov 5), 201–209.
2. [2] Theriot, C.M., Young, V.B., Interactions between the gastrointestinal microbiome and Clostridium difficile. Annu. Rev. Microbiol. 69 (2015 Oct 15), 445–461.
3. [3] Kampmann, C., Dicksved, J., Engstrand, L., Rautelin, H., Composition of human faecal microbiota in resistance to Campylobacter infection. Clin. Microbiol. Infect., 22(1), 2015 Sep 11 61.e1–8.
4. [4] Oh, J.Z., Ravindran, R., Chassaing, B., Carvalho, F.A., Maddur, M.S., Bower, M., et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 41:3 (2014 Sep 18), 478–492.
5. [5] Avendano-Perez, G., Nueno-Palop, C., Narbad, A., George, S.M., Baranyi, J., Pin, C., Interactions of Salmonella enterica subspecies enterica serovar typhimurium with gut bacteria. Anaerobe 33 (2015 Jun), 90–97.
6. [6] Zihler, A., Le, B.G., de, W.T., Lacroix, C., Braegger, C.P., Lehner, A., et al. In vitro inhibition activity of different bacteriocin-producing Escherichia coli against Salmonella strains isolated from clinical cases. Lett. Appl. Microbiol. 49:1 (2009 Jul), 31–38.
7. [7] Fagundes, C.T., Amaral, F.A., Vieira, A.T., Soares, A.C., Pinho, V., Nicoli, J.R., et al. Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice. J. Immunol. 188:3 (2012 Feb 1), 1411–1420.
8. [8] Gauguet, S., D'Ortona, S., Ahnger-Pier, K., Duan, B., Surana, N.K., Lu, R., et al. Intestinal microbiota of mice influences resistance to Staphylococcus aureus pneumonia. Infect. Immun. 83:10 (2015 Oct), 4003–4014.
9. [9] Brenchley, J.M., Price, D.A., Schacker, T.W., Asher, T.E., Silvestri, G., Rao, S., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12:12 (2006 Dec), 1365–1371.
10. [10] Gilks, C.F., Brindle, R.J., Otieno, L.S., Simani, P.M., Newnham, R.S., Bhatt, S.M., et al. Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 336:8714 (1990 Sep 1), 545–549.
11. [11] Munier, A.L., de Lastours, V., Porcher, R., Donay, J.L., Pons, J.L., Molina, J.M., Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era. Int. J. STD AIDS 25:14 (2014 Dec), 1022–1028.
12. [12] Preziosi, M.J., Kandel, S.M., Guiney, D.G., Browne, S.H., Microbiological analysis of nontyphoidal Salmonella strains causing distinct syndromes of bacteremia or enteritis in HIV/AIDS patients in San Diego, California. J. Clin. Microbiol. 50:11 (2012 Nov), 3598–3603.
13. [13] Aragon, T.J., Vugia, D.J., Shallow, S., Samuel, M.C., Reingold, A., Angulo, F.J., et al. Case-control study of shigellosis in San Francisco: the role of sexual transmission and HIV infection. Clin. Infect. Dis. 44:3 (2007 Feb 1), 327–334.
14. [14] Lam, L.H., Monack, D.M., Intraspecies competition for niches in the distal gut dictate transmission during persistent Salmonella infection. PLoS Pathog., 10(12), 2014 Dec, e1004527.
15. [15] Dubourg, G., Lagier, J.C., Armougom, F., Robert, C., Hamad, I., Brouqui, P., et al. The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics. Eur. J. Clin. Microbiol. Infect. Dis. 32:5 (2013 May), 637–645.
16. [16] Araujo-Perez, F., McCoy, A.N., Okechukwu, C., Carroll, I.M., Smith, K.M., Jeremiah, K., et al. Differences in microbial signatures between rectal mucosal biopsies and rectal swabs. Gut Microbes 3:6 (2012 Nov), 530–535.
17. [17] Ouwehand, A.C., Salminen, S., Arvola, T., Ruuska, T., Isolauri, E., Microbiota composition of the intestinal mucosa: association with fecal microbiota?. Microbiol. Immunol. 48:7 (2004), 497–500.
18. [18] Yu, Z., Morrison, M., Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques 36:5 (2004 May), 808–812.
19. [19] Salonen, A., Nikkila, J., Jalanka-Tuovinen, J., Immonen, O., Rajilic-Stojanovic, M., Kekkonen, R.A., et al. Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J. Microbiol. Methods 81:2 (2010 May), 127–134.
20. [20] van, Z.E., Wisselink, G.J., de, B.W., Stoll, S., Alvarez, R., Kooistra-Smid, A.M., Comparison of the QIAsymphony automated nucleic acid extraction and PCR setup platforms with NucliSens easyMAG and Corbett CAS-1200 liquid handling station for the detection of enteric pathogens in fecal samples. J. Microbiol. Methods 84:2 (2011 Feb), 335–340.
21. [21] Mirsepasi, H., Persson, S., Struve, C., Andersen, L.O., Petersen, A.M., Krogfelt, K.A., Microbial diversity in fecal samples depends on DNA extraction method: easyMag DNA extraction compared to QIAamp DNA stool mini kit extraction. BMC Res. Notes, 7, 2014, 50.
22. [22] Kennedy, N.A., Walker, A.W., Berry, S.H., Duncan, S.H., Farquarson, F.M., Louis, P., et al. The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing. PloS one, 9(2), 2014, e88982.
23. [23] Claassen, S., du, T.E., Kaba, M., Moodley, C., Zar, H.J., Nicol, M.P., A comparison of the efficiency of five different commercial DNA extraction kits for extraction of DNA from faecal samples. J. Microbiol. Methods 94:2 (2013 Aug), 103–110.
24. [24] Kembel, S.W., Wu, M., Eisen, J.A., Green, J.L., Incorporating 16S Gene Copy Number Information Improves Estimates of Microbial Diversity and Abundance. 2012.
25. [25] Vetrovsky, T., Baldrian, P., The variability of the 16S rRNA gene in bacterial genomes and its consequences for bacterial community analyses. PloS one, 8(2), 2013, e57923.
26. [26] Bodilis, J., Nsigue-Meilo, S., Besaury, L., Quillet, L., Variable copy number, intra-genomic heterogeneities and lateral transfers of the 16S rRNA gene in Pseudomonas. PLoS One, 7(4), 2012, e35647.
27. [27] Angly, F.E., Dennis, P.G., Skarshewski, A., Vanwonterghem, I., Hugenholtz, P., Tyson, G.W., CopyRighter: a rapid tool for improving the accuracy of microbial community profiles through lineage-specific gene copy number correction. Microbiome, 2, 2014, 11.
28. [28] MJ1, Claesson, Wang, Q., O'Sullivan, O., Greene-Diniz, R., Cole, J.R., Ross, R.P., Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions. Nucleic Acids Res., 38(22), 2010 Dec.
29. [29] Lagier, J.C., Armougom, F., Million, M., Hugon, P., Pagnier, I., Robert, C., et al. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin. Microbiol. Infect. 18:12 (2012 Dec), 1185–1193.
30. [30] Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:7090 (2006 May 11), 235–238.
31. [31] Muranski, P., Restifo, N.P., Essentials of Th17 cell commitment and plasticity. Blood 121:13 (2013 Mar 28), 2402–2414.
32. [32] Telesford, K.M., Yan, W., Ochoa-Reparaz, J., Pant, A., Kircher, C., Christy, M.A., et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function. Gut Microbes 6:4 (2015 Jul 4), 234–242.
33. [33] Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:6015 (2011 Jan 21), 337–341.
34. [34] Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:7480 (2013 Dec 19), 446–450.
35. [35] Ivanov II, Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:3 (2009 Oct 30), 485–498.
36. [36] Brenchley, J.M., Douek, D.C., The mucosal barrier and immune activation in HIV pathogenesis. Curr. Opin. HIV AIDS 3:3 (2008 May), 356–361.
37. [37] Cecchinato, V., Trindade, C.J., Laurence, A., Heraud, J.M., Brenchley, J.M., Ferrari, M.G., et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol. 1:4 (2008 Jul), 279–288.
38. [38] Littman, D.R., Rudensky, A.Y., Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140:6 (2010 Mar 19), 845–858.
39. [39] Favre, D., Lederer, S., Kanwar, B., Ma, Z.M., Proll, S., Kasakow, Z., et al. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog., 5(2), 2009, e1000295.
40. [40] Favre, D., Mold, J., Hunt, P.W., Kanwar, B., Loke, P., Seu, L., et al. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci. Transl. Med., 2(32), 2010 May 19 32ra36.
41. [41] Chen, Y., Guillemin, G.J., Kynurenine pathway metabolites in humans: disease and healthy States. Int. J. Tryptophan Res. 2 (2009), 1–19 Epub 2009 Jan 8.
42. [42] Jenabian, M.A., El-Far, M., Vyboh, K., Kema, I., Costiniuk, C.T., Thomas, R., et al. Immunosuppressive tryptophan catabolism and gut mucosal dysfunction following early HIV infection. J. Infect. Dis. 212:3 (2015 Aug 1), 355–366.
43. [43] Zelante, T., Iannitti, R.G., Cunha, C., De, L.A., Giovannini, G., Pieraccini, G., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39:2 (2013 Aug 22), 372–385.
44. [44] Estes, J.D., Harris, L.D., Klatt, N.R., Tabb, B., Pittaluga, S., Paiardini, M., et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog., 6(8), 2010, e1001052.
45. [45] Brenchley, J.M., Douek, D.C., Microbial translocation across the GI tract. Annu. Rev. Immunol., 30, 2012, 149.
46. [46] Klatt, N.R., Estes, J.D., Sun, X., Ortiz, A.M., Barber, J.S., Harris, L.D., et al. Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. 5:6 (2012 Nov), 646–657.
47. [47] Hofer, U., Schlaepfer, E., Baenziger, S., Nischang, M., Regenass, S., Schwendener, R., et al. Inadequate clearance of translocated bacterial products in HIV-infected humanized mice. PLoS Pathog., 6(4), 2010 Apr, e1000867.
48. [48] Kedzierska, K., Azzam, R., Ellery, P., Mak, J., Jaworowski, A., Crowe, S.M., Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J. Clin. Virol. 26:2 (2003 Feb), 247–263.
49. [49] Hunt, P.W., Sinclair, E., Rodriguez, B., Shive, C., Clagett, B., Funderburg, N., et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J. Infect. Dis. 210:8 (2014 Oct 15), 1228–1238.
50. [50] Sandler, N.G., Douek, D.C., Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat. Rev. Microbiol. 10:9 (2012 Sep), 655–666.
51. [51] Dillon, S.M., Lee, E.J., Kotter, C.V., Austin, G.L., Dong, Z., Hecht, D.K., et al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol. 7:4 (2014 Jul), 983–994.
52. [52] McHardy, I.H., Li, X., Tong, M., Ruegger, P., Jacobs, J., Borneman, J., et al. HIV Infection is associated with compositional and functional shifts in the rectal mucosal microbiota. Microbiome, 1(1), 2013, 26.
53. [53] Vujkovic-Cvijin, I., Dunham, R.M., Iwai, S., Maher, M.C., Albright, R.G., Broadhurst, M.J., et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci. Transl. Med., 5(193), 2013 193ra91.
54. [54] Yu, G., Fadrosh, D., Ma, B., Ravel, J., Goedert, J.J., Anal microbiota profiles in HIV-positive and HIV-negative MSM. AIDS 28:5 (2014 Mar 13), 753–760.
55. [55] Lozupone, C.A., Li, M., Campbell, T.B., Flores, S.C., Linderman, D., Gebert, M.J., et al. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe 14:3 (2013 Sep 11), 329–339.
56. [56] Mutlu, E.A., Keshavarzian, A., Losurdo, J., Swanson, G., Siewe, B., Forsyth, C., et al. A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog., 10(2), 2014 Feb, e1003829.
57. [57] Dinh, D.M., Volpe, G.E., Duffalo, C., Bhalchandra, S., Tai, A.K., Kane, A.V., et al. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J. Infect. Dis. 211:1 (2015 Jan 1), 19–27.
58. [58] Nowak, P., Troseid, M., Avershina, E., Barqasho, B., Neogi, U., Holm, K., et al. Gut microbiota diversity predicts immune status in HIV-1 infection. AIDS 29:18 (2015 Nov 28), 2409–2418.
59. [59] von Rosenvinge, E.C., Song, Y., White, J.R., Maddox, C., Blanchard, T., Fricke, W.F., Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota. ISME J. 7:7 (2013), 1354–1366.
60. [60] Frank, D.N., Amand, A.L.S., Feldman, R.A., Boedeker, E.C., Harpaz, N., Pace, N.R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U. S. A. 104:34 (2007), 13780–13785.
61. [61] Sokol, H., Seksik, P., Rigottier-Gois, L., Lay, C., Lepage, P., Podglajen, I., et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm. Bowel Dis. 12:2 (2006), 106–111.
62. [62] Larsen, N., Vogensen, F.K., van den Berg, F.W., Nielsen, D.S., Andreasen, A.S., Pedersen, B.K., et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS one, 5(2), 2010, e9085.
63. [63] Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., et al. A core gut microbiome in obese and lean twins. Nature 457:7228 (2009 Jan 22), 480–484.
64. [64] Chang, J.Y., Antonopoulos, D.A., Kalra, A., Tonelli, A., Khalife, W.T., Schmidt, T.M., et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile−associated diarrhea. J. Infect. Dis. 197:3 (2008), 435–438.
65. [65] Ferreira, R.B., Gill, N., Willing, B.P., Antunes, L.C., Russell, S.L., Croxen, M.A., et al. The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization. PLoS One, 6(5), 2011, e20338.
66. [66] Leclercq, S., Matamoros, S., Cani, P.D., Neyrinck, A.M., Jamar, F., Starkel, P., et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc. Natl. Acad. Sci. U. S. A. 111:42 (2014 Oct 21), E4485–E4493.
67. [67] Dillon, S.M., Lee, E.J., Kotter, C.V., Austin, G.L., Gianella, S., Siewe, B., et al. Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection. Mucosal Immunol. 9:1 (2015 Apr 29), 24–37.
68. [68] Sokol, H., B+, Pigneur, Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L.G., Gratadoux, J.J., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U. S. A. 105:43 (2008), 16731–16736.
69. [69] Nagalingam, N.A., Lynch, S.V., Role of the microbiota in inflammatory bowel diseases. Inflamm. Bowel Dis. 18:5 (2012 May), 968–984.
70. [70] Kassinen, A., Krogius-Kurikka, L., Makivuokko, H., Rinttila, T., Paulin, L., Corander, J., et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133:1 (2007 Jul), 24–33.
71. [71] Antharam, V.C., Li, E.C., Ishmael, A., Sharma, A., Mai, V., Rand, K.H., et al. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J. Clin. Microbiol. 51:9 (2013 Sep), 2884–2892.
72. [72] Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334:6052 (2011 Oct 7), 105–108.
73. [73] Michail, S., Lin, M., Frey, M.R., Fanter, R., Paliy, O., Hilbush, B., et al. Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease. FEMS Microbiol. Ecol. 91:2 (2015 Feb), 1–9.
74. [74] Jiang, W., Wu, N., Wang, X., Chi, Y., Zhang, Y., Qiu, X., et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci. Rep., 5, 2015, 8096.
75. [75] Lucke, K., Miehlke, S., Jacobs, E., Schuppler, M., Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. J. Med. Microbiol. 55:Pt 5 (2006 May), 617–624.
76. [76] Wright, D.P., Rosendale, D.I., Robertson, A.M., Prevotella enzymes involved in mucin oligosaccharide degradation and evidence for a small operon of genes expressed during growth on mucin. FEMS Microbiol. Lett. 190:1 (2000 Sep 1), 73–79.
77. [77] Round, J.L., Mazmanian, S.K., Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U. S. A. 107:27 (2010 Jul 6), 12204–12209.
78. [78] Faith, J.J., Ahern, P.P., Ridaura, V.K., Cheng, J., Gordon, J.I., Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci. Transl. Med., 6(220), 2014 Jan 22 220ra11.
79. [79] Kverka, M., Zakostelska, Z., Klimesova, K., Sokol, D., Hudcovic, T., Hrncir, T., et al. Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin. Exp. Immunol. 163:2 (2011 Feb), 250–259.
80. [80] Lathrop, S.K., Bloom, S.M., Rao, S.M., Nutsch, K., Lio, C.W., Santacruz, N., et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 478:7368 (2011 Oct 13), 250–254.
81. [81] Lozupone, C.A., Rhodes, M.E., Neff, C.P., Fontenot, A.P., Campbell, T.B., Palmer, B.E., HIV-induced alteration in gut microbiota: Driving factors, consequences, and effects of antiretroviral therapy. Gut Microbes 5:4 (2014 Jul 1), 562–570.
82. [82] Neff, C., Rhodes, M., Donnely, J., Schneider, J., Mazmanian, S., Lozupone, C., et al. IL-10 inducing bacteria are preferentially depleted in the gut of HIV infected subjects. J. Immunol., 194, 2015.
83. [83] Marchetti, G., Bellistri, G.M., Borghi, E., Tincati, C., Ferramosca, S., La, F.M., et al. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. Aids 22:15 (2008 Oct 1), 2035–2038.
84. [84] Redd, A.D., Eaton, K.P., Kong, X., Laeyendecker, O., Lutalo, T., Wawer, M.J., et al. C-reactive protein levels increase during HIV-1 disease progression in Rakai, Uganda, despite the absence of microbial translocation. J. Acquir Immune Defic. Syndr. 54:5 (2010 Aug), 556–559.
85. [85] Winter, S.E., Thiennimitr, P., Winter, M.G., Butler, B.P., Huseby, D.L., Crawford, R.W., et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467:7314 (2010 Sep 23), 426–429.
86. [86] Winter, S.E., Winter, M.G., Xavier, M.N., Thiennimitr, P., Poon, V., Keestra, A.M., et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339:6120 (2013 Feb 8), 708–711.
87. [87] Dillon, S.M., Manuzak, J.A., Leone, A.K., Lee, E.J., Rogers, L.M., McCarter, M.D., et al. HIV-1 infection of human intestinal lamina propria CD4+ T cells in vitro is enhanced by exposure to commensal Escherichia coli. J. Immunol. 189:2 (2012 Jul 15), 885–896.
88. [88] Manner, I.W., Baekken, M., Kvale, D., Oektedalen, O., Pedersen, M., Nielsen, S.D., et al. Markers of microbial translocation predict hypertension in HIV-infected individuals. HIV Med. 14:6 (2013 Jul), 354–361.
89. [89] Gori, A., Tincati, C., Rizzardini, G., Torti, C., Quirino, T., Haarman, M., et al. Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J. Clin. Microbiol. 46:2 (2008), 757–758.
90. [90] Perez-Santiago, J., Gianella, S., Massanella, M., Spina, C.A., Karris, M.Y., Var, S.R., et al. Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection. AIDS 27:12 (2013 Jul 31), 1921–1931.
91. [91] Stiksrud, B., Nowak, P., Nwosu, F.C., Kvale, D., Thalme, A., Sonnerborg, A., et al. Reduced levels of D-dimer and changes in gut microbiota composition after probiotic intervention in HIV-infected individuals on stable ART. J. Acquir Immune Defic. Syndr. 70:4 (2015 Dec 1), 329–337.
92. [92] d'Ettorre, G., Ceccarelli, G., Giustini, N., Serafino, S., Calantone, N., De, G.G., et al. Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: results of the “Probio-HIV” clinical trial. PLoS One, 10(9), 2015, e0137200.